Galmed Pharmaceuticals
GLMD
#10351
Rank
NZ$3.97 M
Marketcap
$2.40
Share price
-8.22%
Change (1 day)
-63.23%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2023 (TTM): -$11.15

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$11.97. In 2022 the company made an earnings per share (EPS) of -$18.90 an increase over its 2021 EPS that were of -$35.41.

EPS history for Galmed Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$11.15-41.01%
2022-$18.90-46.62%
2021-$35.41-2.22%
2020-$36.2239.18%
2019-$26.0270.18%
2018-$15.29-41.84%
2017-$26.29-34.23%
2016-$39.9756.84%
2015-$25.499.2%
2014-$23.34-53.43%
2013-$50.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.31-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.19-39.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-$1.34-88.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.22-64.72%๐Ÿ‡บ๐Ÿ‡ธ USA